Healthcare Triangle Inc.
We are a healthcare information technology company focused on advancing innovative industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the Electronic Health Record (EHR), Healthcare and Life Sciences industry. Our approach leverages our proprietary technology platforms, extensive industry knowledge, and healthcare domain expe…
$0.40
-$0.02 (-4.56%)
EOD Oct 16, 2026
The business is unprofitable at the operating level (-70.56% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 18.2%, still solid. Margins contracted 30.1pp, which offsets some of the top-line progress.
Negative free cash flow of -$17M. The business is consuming cash, not generating it. Operating margin contracted 30.1pp YoY, cost discipline may be slipping.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$26M
▲ +18.2% YoY
Net Income (TTM)
-$17M
▼ -58.8% YoY
Op. Margin
-57.71%
▼ -30.1pp YoY
ROIC
-3.96%
▲ +85.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$16M
▼ -1429.0% YoY
Op. Cash Flow (TTM)
-$16M
▼ -1428.5% YoY
Net Debt
$22M
Cash & Equiv.
$2M
5Y CAGR: -15.0%
Continue Research
SourceComputed from the 10-Q filed 12 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Price from market data, last close as of 16 Oct 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
Is Healthcare Triangle (HCTI) overvalued?
Healthcare Triangle (HCTI)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Healthcare Triangle scores 0/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Healthcare Triangle a high-quality business?+
Healthcare Triangle scores 0 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -57.7% operating margin and a -4.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Healthcare Triangle a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh HCTI's valuation and scores 0/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.
Related stocks: Services-Computer Integrated Systems Design
Spot a number that looks wrong?
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.